Becton Dickinson

The company reported growth across all three of its business segments and reaffirmed its full-year guidance.

The firm also reaffirmed its previous guidance of 10 percent growth for fiscal 2019.

Among the updates provided at the conference on Wednesday, Luminex discussed development and plans for the Verigene II system, and GenMark touted its ePlex test portfolio.

The enteric panel detects the viral cause of infectious diarrhea symptoms including norovirus, rotavirus, adenovirus, human astrovirus, and sapovirus.

The lawsuit comes a few days after a jury awarded Bio-Rad Laboratories $23.9 million in damages in a patent infringement suit against 10x Genomics.

The firm's full fiscal year revenues were also up, 32 percent as reported, or about 6 percent on a currency-neutral basis.

The PCR assay is intended to help detect TB-causing bacteria and determine if it harbors mutations associated with isoniazid and rifampicin resistance.